Latest papers

Platelet function testing in practice: a case study.

Platelet aggregation inhibitors, platelet function testing, and blood loss in hip fracture surgery.

Platelet aggregation monitoring with a newly developed quartz crystal microbalance system as an alternative to optical platelet aggregometry.

The genetics of normal platelet reactivity.

New trends in bioanalytical microdevices to assess platelet function.

A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.

A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.

Perioperative assessment of platelet function in patients under antiplatelet therapy.

Development of a high-throughput ELISA assay for platelet function testing using platelet-rich plasma or whole blood.

Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.

Mean platelet volume in obese adolescents with nonalcoholic fatty liver disease.

High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.

Validation of a novel ELISA-based VASP whole blood assay to measure P2Y12-ADP receptor activity.

The in vitro effects of niacin on platelet biomarkers in human volunteers.

Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.

Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy.

Slippery platelet syndromes in subdural hematoma.

Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate).

Compound heterozygous mutations in 2 siblings with Hermansky-Pudlak syndrome type 1 (HPS1).

Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies.